HomeREVB • NASDAQ
add
Revelation Biosciences Inc
Previous close
$1.24
Day range
$1.22 - $1.33
Year range
$1.19 - $45.60
Market cap
4.80M USD
Avg Volume
1.25M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.57M | 46.62% |
Net income | -2.51M | -45.50% |
Net profit margin | — | — |
Earnings per share | -1.65 | 97.24% |
EBITDA | -2.57M | -46.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.76M | 65.54% |
Total assets | 11.58M | 74.91% |
Total liabilities | 2.72M | 42.24% |
Total equity | 8.86M | — |
Shares outstanding | 3.72M | — |
Price to book | 0.22 | — |
Return on assets | -52.61% | — |
Return on capital | -62.39% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.51M | -45.50% |
Cash from operations | -1.97M | 47.51% |
Cash from investing | — | — |
Cash from financing | -41.17K | -101.12% |
Net change in cash | -2.01M | -4,677.46% |
Free cash flow | -1.04M | 66.46% |
About
Founded
2019
Website
Employees
8
